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Synthetic Experimental for S-diastereomers and racemic mixtures 4 Figure S1 . Synthetic Scheme for α-series 8 Figure S2 . Synthetic Scheme for the β-series 8
Part 2 Figure S3 . 1 H NMR R-(+)-2-bromopropan-1-ol (7a) 9 Figure S4 . 13 C NMR R-(+)-2-bromopropan-1-ol (7a) 10 S-(-)-2-bromopropan-1-ol (7b). The same procedure was used as described for 7a beginning with 3.0 mL (5.09 g, 0.033 mol) of S-(-)-2-bromopropionic acid. S-(-)-2-bromopropan-1-β β β β-D-galactose tetraacetate (8b). The S-diastereomer was synthesized by the same procedure described for 8a beginning with 0.2820 g (0.0020 mol) 7b in a 74.4% yield. 87, 20.95, 21.14, 22.69, 46.15, 61.44, 67.14, 68.80, 70.91, 70.97, 75.14, 101.91, 170.28, 170.36, 170.54 . ESI-MS m/z = 492.8 (M + Na + ).
2-bromopropan-1-β β β β-D-galactose tetraacetate (8c).
The racemic mixture of 8 was synthesized by the same procedure as for 8a beginning with 6.46 g (0.046 mol) 7c in a yield of 70%. 13 C NMR (100 MHz) δ 20. 49, 20.57, 20.78, 20.94, 22.19, 22.37, 45.95, 46.34, 60.27, 61.19, 66.96, 68.53, 68.60, 70.67, 74.84, 75.07, 101.31, 101.60, 169.36, 169.99, 170.14, 170.26 . ESI-MS m/z = 492.8 (M+Na + ). 13 C NMR (125 MHz, CD 3 CN) δ 7. 92, 20.15, 20.30, 20.37, 20.40, 53.41, 61.52, 67.47, 68.76, 70.56, 72.04, 73.49. 104.5, 170.02, 170.75, 170.79, 171.28 13 C NMR (125 MHz, CD 3 CN) δ 7. 85, 8.20, 20.09, 20.21, 20.34, 53.11, 53.43, 61.29, 61.52, 67.47, 67.66, 68.77, 69.09, 70.31, 70.56, 70.89, 71.55, 72.07, 101.5, 104.5, 170.02, 170.26, 170.55, 171.27, 171.49 13 C NMR (CD 3 CN, 125 MHz) δ 20. 72, 20.76, 20.90, 54.40, 60.33, 67.32, 68.72, 70.25, 71.43, 71.54, 101.24, 169.46, 169.93, 170.75, 171.48 . ESI-MS: m/z = 777.6 (M + H + ), 799.5 (M + Na + ).
S-(-)-(
(2-(4,7,10-trismethylcarboxymethyl-(1,4,7,10-tetraazacyclododecyl))propan)-1-β β β β-Dgalactose tetraacetate (10c). The racemic mixture was synthesized according to procedure described for 10a beginning with 1.0148 g of 9c. Yield was calculated over the last two reactions beginning with 8c: 37%.
1 H NMR (500 MHz, CD 3 CN) δ 1.2-1.3 (d, 3H, methyl, J = 6.0), 1.9-2.2 (m, 12H, OAc), 2.4-3.6 (br, 16H, cyclen), 3.65-3.8 (m, 9H, -OCH 3 ), 3.9-4.2 (br, methylene and methine on linker and H-6), 4.6 (m, 1H, H-4), 4.7 (m, 1H, H-5), 5.0-5.2 (m, 1H, H-3), 5.4 (m, 1H, H-2), 5.5 (s, 1H, H-1).
13
C NMR (125 MHz, CD 3 CN) δ 20. 05, 20.10, 20.20, 20.35, 20.38, 51.17, 51.41, 51.46, 52.18, 52.28, 52.38, 52.52, 55.12, 55.57, 55.67, 61.49, 61.55, 67.55, 67.62, 68.95, 69.06, 69.14, 70.68, 70.80, 70.96, 71.13, 100.48, 101.24, 170.05, 170.48, 171.30, 171.51, 171.57, 174.33, 174.76, 175.15 . ESI-MS: m/z = 777.2 (M + H + ), 799.2 (M + Na + ).
Kinetic resolution of S-(-)-propylene oxide (11b).
Propylene oxide was kinetically resolved as described above beginning with 5 mL (4.15 g, 0.071 mol) of propylene oxide and 0.008 eq. of (S,S)-(+)-N,N'-bis (3,5-di-tertbutylsalicylidene)-1,2-cyclohexane diaminocobalt(II 
S-(-)-1-bromopropan-2-ol (12b).
The S-diastereomer was synthesized using the procedure described for 12a beginning with 8 mL (6.63 g, 0.11 mol) of 11b. Yield: 57%. 
1-bromopropan-2-ol (12c).
The racemic mixture of 12 was synthesized according to the procedure described for 12a beginning with 10 mL (8.29 g, 0.14 mol) of 11c. 
S-(-)-1-bromopropan-2-β β β β-D-galactose tetraacetate (13b).
The S-diastereomer was synthesized using the procedure described for 13a beginning with 4.3867 g (0. 85, 20.94, 21.01, 21.28, 36.23, 61.18, 67.13, 68.86, 70.79, 70.98, 76.98, 101.67, 168.57, 176.13, 170.27, 170.37 . ESI-MS: m/z = 493.0 (M + Na + ), 509.2 (M + K + ).
1-bromo-propan-2-β β β β-D-galactose tetraacetate (13c).
The racemic mixture was synthesized using the procedure described for 13a beginning with 5.2619 g (0. 92, 20.55, 20.89, 20.92, 20.98, 36.18, 36.52, 61.54, 62.09, 62.14, 66.77, 67.17, 67.66, 67.71, 68.22, 68.30, 68.39, 68.47, 70.87, 71.03, 75.00, 75.37, 95.25, 96.70, 170.46, 170.67, 170.69, 170.88 . ESI-MS: m/z = 493.1 (M + Na + ), 509.1 (M + K + ). 1-(1,4,7 ,10-tetraazacyclododecyl)propan-2-β β β β-D-galactose tetraacetate (14b). The S-diastereomer was synthesized using the method described for 14a beginning with 3.1863 g (0.0068 mol) of 13b.
S-(-)-
1 H NMR (500 MHz, CDCl 3 ) δ 1.08-1.18 (d, 3H, methyl, J = 6.5), 1.95-2.28 (m, 12H, OAc), 2.70 (s, 2H, methylene on linker), 2.90-3.50 (br, 16H, cyclen), 3.90-4.02 (m, 1H, methine on linker), 4. 16-4.24 (m, 1H, H-5), 4.25-4.36 (m, 2H, H-6), 4.62-4.68 (m, 1H, H-4), 4.90-4.98 (m, 1H, H-3), 5.02-5.12 (m, 1H, H-2), 5.42 (m, 1H, H-1) . ESI-MS: m/z = 561.2 (M + H + ).
1-(1,4,7,10-tetraazacyclododecyl)propan-2-β β β β-D-galactose tetraacetate (14c). The racemic mixture was synthesized according to the method described for 14a beginning with 3.5534 g (0.0076 mol) of 13c.
1 H NMR (500 MHz, CDCl 3 ) δ 1.08-1.16 (d, 3H, methyl, J = 6.5), 1.95-2.30 (m, 12H, OAc), 2.70 (s, 2H, methylene on linker), 2.92-3.52 (br, 16H, cyclen), 3.90-4.02 (m, 1H, methine on linker), 4.18-4.28 (m, 1H, H-5), 4.25-4.36 (m, 2H, H-6), 4.62-4.68 (m, 1H, H-4), 4.90-4.98 (m, 1H, H-3), 5.02-5.12 (m, 1H, H-2), 5.42 (m, 1H, H-1) . ESI-MS: m/z = 561.2 (M + H + ).
S-(-)-1-(4,7,10-trismethylcarboxymethyl-(1,4,7,10-tetraazacyclododecyl))propan-2-β β β β-D-galactose tetraacetate (15b). The S-diastereomer was synthesized using the procedure described for 15a beginning with 1.6147 g (0.0029 mol) of 14b. 39, 20.74, 20.89, 21.41, 48.31, 50.69, 51.96, 52.09, 52.89, 52.96, 55.69, 55.99, 55.87, 61.56, 67.26, 67.38, 69.31, 69.42, 70.87, 70.94, 71.41, 73.25, 95.01, 100.98, 169.66, 169.96, 170.08, 170.17, 170.42, 170.62, 171.40, 171.82, 174. 20 . ESI-MS: m/z = 777.2 (M + H + ), 799.3 (M + Na + ).
1-(4,7,10-trismethylcarboxymethyl-(1,4,7,10-tetraazacyclododecyl))propan-2-β β β β-Dgalactose tetraacetate (15c). The racemic mixture was synthesized using the method described for 15a beginning with 1.6173 g (0.0029 mol) of 14c. 52.98, 55.87, 56.16, 61.59, 66.86, 67.51, 67.94, 70.63, 94.51, 95.01, 170.39, 170.54, 170.72, 171.24, 171.41, 171.59, 174.27, 174.92 
